Comparison of Outcomes of Multiple Platforms for Assisted Robotic - Gastrectomy

Launched by AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA · Apr 8, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at different robotic surgical platforms used for a procedure called gastrectomy, which involves removing part or all of the stomach due to gastric cancer. The trial compares three robotic systems: DaVinci, Hugo, and Versius. Researchers want to see if there are any differences in the safety and effectiveness of these systems during and after surgery, as well as how quickly surgeons can learn to use them effectively.

To participate, individuals must be between 18 and 80 years old and have a primary stomach tumor that requires surgery. Participants can be newly diagnosed or may have already received chemotherapy before surgery. During the trial, patients will receive surgery using one of the three robotic systems, and they will be closely monitored for any complications or issues that arise. This study aims to improve surgical techniques for treating gastric cancer and enhance patient outcomes.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age \> 18 and \< 80 years
• • Informed consent provided
• • Primary stomach tumor
• • Total or subtotal gastrectomy
• • Tumour stage: T1-4a, any N, M0
• • ASA I-III
• • No BMI limits
• • Upfront surgery or after neoadjuvant chemotherapy
• Exclusion Criteria:
• • Extension to esophagectomy
• • Tumor of the esophago-gastric junction (Siwert I-III)
• • Emergency surgery
• • Metastatic patients (stage IV)
• • Patients undergoing preoperative radiotherapy
• • Previous major supramesocolic surgery (excluding cholecystectomy)
• • Other coexisting malignant neoplasms